Navigation Links
Forte Launches Probate Finder OnDemandâ„¢
Date:8/4/2010

MINNEAPOLIS, Aug. 4 /PRNewswire/ -- Forte, LLC, today announced the availability of Probate Finder OnDemand™, a web-based probate database and estate recovery application that significantly improves deceased debt collections through probate. Probate Finder OnDemand provides access to a proprietary database of more than three million probated estate records, powerful matching algorithms that accurately match deceased accounts to estate records and automated workflows that simplify claim preparation and management resulting in improved deceased debt recovery performance.

"For years, the world's largest banks and lending institutions have used our Probate Finder® database to recover deceased accounts through probate – the most effective, survivor-sensitive way to collect on deceased debt," said Steven Farsht, CEO, Forte. "Today, through unprecedented innovation and powerful web technologies, Probate Finder OnDemand brings the benefits of Probate Finder to your desktop."

By harnessing the power of the Probate Finder database, the most advanced and comprehensive database of probated estate information anywhere, Probate Finder OnDemand puts the user in control of the probate process. An intuitive interface and powerful web-based technologies simplify the user experience and make recovering deceased accounts efficient and effective. The web-based solution needs no new hardware or software while users require little training or specialized knowledge. There is no fee for searching and users only pay when a match is identified. Other features include:

  • Access to more than three million probated estate records
  • Online access to right party contact information
  • Simple, fully automated account uploading process
  • Automated, hourly matching of estate records and accounts
  • Effortless document storage and retrieval
  • Coverage of all the nation's more than 3,450 probate courts
  • Information Security Program certified to the ISO27001 international security standard and HIPAA compliant, ensuring maximum data security and regulatory compliance
  • Desktop application includes comprehensive online help and support

With an initial focus on the healthcare industry, Probate Finder OnDemand's ease of use and automated access to the nation's probate courts drove interest from a diverse group of healthcare providers. "Probate Finder OnDemand makes the whole process of finding estates and filing claims so much easier," said Deborah Ivy, billing manager, South Texas Oncology and Hematology, an eight-facility practice in the southwest U.S that had pre-release access to the application. "Without Probate Finder OnDemand, I wouldn't know where to start."

Using only a web browser and an Internet connection, Probate Finder OnDemand makes it easy for users to add accounts into the system, match them against more than three million probated estate records and manage the claims recovery process.

To learn more about Probate Finder OnDemand, please visit www.probatefinder.com or call 1.888.423.0522.

About Forte

Forte is the industry leader in probate data and solutions that increase probate recoveries. Forte helps organizations maximize recoveries on probate accounts while protecting their reputation and relationships.  Harnessing the power of its patent-pending technologies, Forte delivers innovative, data-driven solutions that are transforming the way organizations deal with the death of a customer. Visit www.probatefinder.com to learn more.


'/>"/>
SOURCE Forte, LLC
Copyright©2010 PR Newswire.
All rights reserved

Related biology technology :

1. A Better Tomorrow Treatment Center Inc., Forterus Inc.s Behavioral Healthcare Subsidiary, is the First in the Nation to Offer DNA-Customized Treatment for Individuals with a Genetic Predisposition for Addictive Behavior
2. ForteBio, Inc. Closes $25 Million In Series C Financing
3. ForteBio Launches New Assay Capabilities for High-Sensitivity Protein Quantitation and Fragment Screening on Its Octet(R) Platform
4. ForteBio Launches Two Revolutionary High-Throughput, Label-Free Instruments: The Octet(R) RED384 and the Octet QK384
5. Fortebio, Inc. to Present at UBS Global Life Sciences Conference
6. Hooper Holmes Heritage Labs Division Launches New Home Diabetes Test
7. ICON Medical Imaging Launches New Service to Boost Reliability of Cardiology Studies
8. StollerUSA Launches Bio-Forge.com to Offer Solutions for Crops Under Stress
9. GEECF: Spectrum Launches Zero Waste Philippines and Gears Towards Cheap Green Energy
10. ETEX Launches Innovative Osteoinductive Orthobiologic, EquivaBone(TM)
11. ChemAxon Launches Marvin and JChem Version 5.1; Name to Structure Generation, OLE 2 and JavaScript Integration
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/24/2017)... 2017 China Cord Blood Corporation (NYSE: ... provider of cord blood collection, laboratory testing, hematopoietic stem ... its unaudited financial results for the third quarter and ... 31, 2016. Third Quarter of Fiscal 2017 ... of fiscal 2017 increased by 18.6% to RMB200.9 million ...
(Date:2/24/2017)... (NASDAQ: VWR), the leading global independent provider of product and ... financial results for the fourth quarter and full year ended ... 4Q16 record quarterly net sales of $1.13 billion, up 1.6% ... 4Q16 EMEA-APAC segment net sales increased 0.4%, ... sales increased 2.5%, or down 0.9% on an organic basis, ...
(Date:2/23/2017)... 2017 ... share data, unaudited)Three Months Ended December 31,Twelve Months Ended ... $           ... 89026%Aldurazyme Net Product Revenue 3539(10)%9498(4)%Kuvan ... Product Revenue  756025%297303(2)%Vimizim Net Product ...
(Date:2/23/2017)... JOSE, Calif. , Feb. 23, 2017 /PRNewswire/ ... exclusive license for two key immunotherapy technologies from ... first technology provides a method to monitor a ... such as PD-L1 and CTLA-4.  The second license ... if a patient is likely to have an ...
Breaking Biology Technology:
(Date:2/2/2017)... 2017   TapImmune, Inc. (NASDAQ: ... in the development of innovative peptide and gene-based ... and metastatic disease, announced today it has successfully ... a second clinical lot of TPIV 200, the ... The manufactured vaccine product will be used to ...
(Date:1/31/2017)... 31, 2017  Spero Therapeutics, LLC, a biopharmaceutical ... treatment of bacterial infections, today announced it has ... from Pro Bono Bio Ltd (PBB) to bolster ... resistant forms of Gram-negative bacteria.   The assets acquired ... a PBB group company. "The acquisition ...
(Date:1/25/2017)... , Jan. 25, 2017 The Elements of ... (IAM) lifecycle is comprised of a comprehensive set ... purpose of maintaining digital identities and providing a ... applications. There are significant number of programs opted ... to time by optimizing processes and changing policies. ...
Breaking Biology News(10 mins):